4 companies in Asabys Partners's investment portfolio.
Back to Asabys Partners profile“Focuses on early-stage life sciences and digital health companies in Europe, particularly therapeutics, medical devices, and healthtech platforms.”
Spanish biopharmaceutical company developing innovative treatments for oncology and other therapeutic areas.
Norwegian biotech company developing blood-brain barrier technology to improve drug delivery for treating neurological diseases.
Biopharmaceutical company developing treatments for rare neurological diseases and CNS disorders.
Spanish biopharmaceutical company developing epigenetic therapies for cancer and CNS diseases using histone deacetylase and lysine demethylase inhibitors.
Asabys Partners has built a portfolio of 4 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO, Seed stages, showing Asabys Partners's approach to supporting companies at multiple points in their growth journey.
Asabys Partners has invested in 4+ companies across 1 different sectors.
Asabys Partners's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
Asabys Partners invests across the IPO, Seed stages. Their portfolio includes companies at various points in their growth journey.
VentureKit
Turn your thesis into a complete fund launch package — strategy memo, LP pitch deck, financial models, and 11 more custom documents. Generated in 24 hours.
Build Your Fund Package